HelloKitty55
2021-12-24
Ok
Ortho Clinical Diagnostics shares surged 11% in premarket trading<blockquote>Ortho Clinical Diagnostics股价在盘前交易中飙升11%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":698343023,"tweetId":"698343023","gmtCreate":1640310228374,"gmtModify":1640310230718,"author":{"id":3587095479419511,"idStr":"3587095479419511","authorId":3587095479419511,"authorIdStr":"3587095479419511","name":"HelloKitty55","avatar":"https://static.tigerbbs.com/d60ee63e7e29d36d5bc7561ef9bc3ed6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":33,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/698343023","repostId":1179225984,"repostType":4,"repost":{"id":"1179225984","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640262946,"share":"https://www.laohu8.com/m/news/1179225984?lang=zh_CN&edition=full","pubTime":"2021-12-23 20:35","market":"us","language":"en","title":"Ortho Clinical Diagnostics shares surged 11% in premarket trading<blockquote>Ortho Clinical Diagnostics股价在盘前交易中飙升11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1179225984","media":"Tiger Newspress","summary":"Ortho Clinical Diagnostics shares surged 11% in premarket trading.\nQuidel Corporation(NASDAQ:QDEL)ha","content":"<p>Ortho Clinical Diagnostics shares surged 11% in premarket trading.<img src=\"https://static.tigerbbs.com/d23b5b89b89ee4bfdc55d23585e0005f\" tg-width=\"700\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote>Ortho Clinical Diagnostics股价在盘前交易中飙升11%。</blockquote></p><p> Quidel Corporation(NASDAQ:QDEL)has agreed to acquire Ortho Clinical Diagnostics(NASDAQ:OCDX)for $24.68 per share of common stock for a total equity value of nearly $6B, the companies announced Thursday. Both Ortho Clinical (OCDX) and Quidel (QDEL) shares are currently on hold for trading.</p><p><blockquote>Quidel Corporation（纳斯达克：QDEL）周四宣布，已同意以每股24.68美元的普通股收购Ortho Clinical Diagnostics（纳斯达克：OCDX），总股本价值近60亿美元。Ortho Clinical(OCDX)和Quidel(QDEL)股票目前均暂停交易。</blockquote></p><p> According to the definitive agreement signed by the parties, Quidel (QDEL) has offered cash and newly issued shares in the combined company indicating a 25% premium for Ortho’s closing price on Dec. 22, 2022.</p><p><blockquote>根据双方签署的最终协议，Quidel(QDEL)已提供现金和合并后公司新发行的股票，较Ortho 2022年12月22日的收盘价溢价25%。</blockquote></p><p> Per the terms, for each Ortho (OCDX) share they won, Ortho investors are set to receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined entity. They will own nearly 38% of the combined company, which will be led by Quidel’s current President and CEO, Douglas Bryant.</p><p><blockquote>根据条款，Ortho投资者每赢得一股Ortho(OCDX)股票，将获得每股普通股7.14美元现金和合并后实体中0.1055股普通股。他们将拥有合并后公司近38%的股份，该公司将由Quidel现任总裁兼首席执行官Douglas Bryant领导。</blockquote></p><p> With the acquisition of Ortho Clinical (OCDX), a player in vitro diagnostic, Quidel (QDEL) expects to generate an estimated $90M cost synergies by year three in the combined company. The deal is also anticipated to yield revenue synergies over $100M by 2025 and opportunitiesfor adjusted EBITDA margin expansion.</p><p><blockquote>通过收购体外诊断公司Ortho Clinical(OCDX)，Quidel(QDEL)预计到第三年将在合并后的公司产生约9000万美元的成本协同效应。预计到2025年，该交易还将产生超过1亿美元的收入协同效应，并带来调整后EBITDA利润率扩张的机会。</blockquote></p><p> A few days ago, JPMorgan identified Quidel (QDEL) as one of its top picks to short in 2022.</p><p><blockquote>几天前，摩根大通将Quidel(QDEL)确定为2022年做空的首选之一。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ortho Clinical Diagnostics shares surged 11% in premarket trading<blockquote>Ortho Clinical Diagnostics股价在盘前交易中飙升11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrtho Clinical Diagnostics shares surged 11% in premarket trading<blockquote>Ortho Clinical Diagnostics股价在盘前交易中飙升11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-23 20:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Ortho Clinical Diagnostics shares surged 11% in premarket trading.<img src=\"https://static.tigerbbs.com/d23b5b89b89ee4bfdc55d23585e0005f\" tg-width=\"700\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote>Ortho Clinical Diagnostics股价在盘前交易中飙升11%。</blockquote></p><p> Quidel Corporation(NASDAQ:QDEL)has agreed to acquire Ortho Clinical Diagnostics(NASDAQ:OCDX)for $24.68 per share of common stock for a total equity value of nearly $6B, the companies announced Thursday. Both Ortho Clinical (OCDX) and Quidel (QDEL) shares are currently on hold for trading.</p><p><blockquote>Quidel Corporation（纳斯达克：QDEL）周四宣布，已同意以每股24.68美元的普通股收购Ortho Clinical Diagnostics（纳斯达克：OCDX），总股本价值近60亿美元。Ortho Clinical(OCDX)和Quidel(QDEL)股票目前均暂停交易。</blockquote></p><p> According to the definitive agreement signed by the parties, Quidel (QDEL) has offered cash and newly issued shares in the combined company indicating a 25% premium for Ortho’s closing price on Dec. 22, 2022.</p><p><blockquote>根据双方签署的最终协议，Quidel(QDEL)已提供现金和合并后公司新发行的股票，较Ortho 2022年12月22日的收盘价溢价25%。</blockquote></p><p> Per the terms, for each Ortho (OCDX) share they won, Ortho investors are set to receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined entity. They will own nearly 38% of the combined company, which will be led by Quidel’s current President and CEO, Douglas Bryant.</p><p><blockquote>根据条款，Ortho投资者每赢得一股Ortho(OCDX)股票，将获得每股普通股7.14美元现金和合并后实体中0.1055股普通股。他们将拥有合并后公司近38%的股份，该公司将由Quidel现任总裁兼首席执行官Douglas Bryant领导。</blockquote></p><p> With the acquisition of Ortho Clinical (OCDX), a player in vitro diagnostic, Quidel (QDEL) expects to generate an estimated $90M cost synergies by year three in the combined company. The deal is also anticipated to yield revenue synergies over $100M by 2025 and opportunitiesfor adjusted EBITDA margin expansion.</p><p><blockquote>通过收购体外诊断公司Ortho Clinical(OCDX)，Quidel(QDEL)预计到第三年将在合并后的公司产生约9000万美元的成本协同效应。预计到2025年，该交易还将产生超过1亿美元的收入协同效应，并带来调整后EBITDA利润率扩张的机会。</blockquote></p><p> A few days ago, JPMorgan identified Quidel (QDEL) as one of its top picks to short in 2022.</p><p><blockquote>几天前，摩根大通将Quidel(QDEL)确定为2022年做空的首选之一。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QDEL":"窥得儿医药","OCDX":"Ortho Clinical Diagnostics Holdings plc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179225984","content_text":"Ortho Clinical Diagnostics shares surged 11% in premarket trading.\nQuidel Corporation(NASDAQ:QDEL)has agreed to acquire Ortho Clinical Diagnostics(NASDAQ:OCDX)for $24.68 per share of common stock for a total equity value of nearly $6B, the companies announced Thursday. Both Ortho Clinical (OCDX) and Quidel (QDEL) shares are currently on hold for trading.\nAccording to the definitive agreement signed by the parties, Quidel (QDEL) has offered cash and newly issued shares in the combined company indicating a 25% premium for Ortho’s closing price on Dec. 22, 2022.\nPer the terms, for each Ortho (OCDX) share they won, Ortho investors are set to receive $7.14 in cash per common share and 0.1055 shares of common stock in the combined entity. They will own nearly 38% of the combined company, which will be led by Quidel’s current President and CEO, Douglas Bryant.\nWith the acquisition of Ortho Clinical (OCDX), a player in vitro diagnostic, Quidel (QDEL) expects to generate an estimated $90M cost synergies by year three in the combined company. The deal is also anticipated to yield revenue synergies over $100M by 2025 and opportunitiesfor adjusted EBITDA margin expansion.\nA few days ago, JPMorgan identified Quidel (QDEL) as one of its top picks to short in 2022.","news_type":1,"symbols_score_info":{"OCDX":0.9,"QDEL":0.9}},"isVote":1,"tweetType":1,"viewCount":834,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/698343023"}
精彩评论